ApprovalTrail

Approval · Notice of Compliance 7306 · 2005

INFUFER: Notice of Compliance 7306

Issued August 22, 2005

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7306
Date
August 22, 2005
Company
Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Haematinic, iron supplement

Products in this notice

BrandDINStatus today
INFUFER02221780Cancelled Post Market

Medicinal ingredients